Ignite Creation Date:
2024-05-06 @ 1:25 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01801111
Status:
COMPLETED
Last Update Posted:
2018-11-02
First Post:
2013-02-20
Brief Title:
A Study of Alectinib RO5424802 in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase ALK Mutation and Failed Crizotinib Treatment
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Organization Data
Organization:
Hoffmann-La Roche
Class:
INDUSTRY
Study ID:
NP28673
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffmann-La Roche
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None